MedPath

The Effects of Acupuncture for Major Trauma

Not Applicable
Conditions
Major Trauma
Registration Number
NCT04970433
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

Major trauma is a significant cause for morbidity and mortality in the world. After traumatic injury, the damage tissue could induce systemic inflammatory response (SIRS) and activate autonomic nervous system in response to stress, followed by compensatory anti-inflammatory response (CARS). Imbalance of SIRS and CARS may lead to organ failures, sepsis and death.

Detailed Description

The investigators design a prospective clinical trial to investigate the efficacy of acupuncture for major trauma.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Male or female aged 20 years or older
  • Confirmed diagnosis of major trauma with ISS ≥ 16
Exclusion Criteria
  • Pregnancy
  • Malignancy
  • Pacemaker
  • Status epilepticus
  • Severe medical disease
  • Life threatening
  • Prior history of drug or alcohol dependence
  • Immunodeficiency
  • Vagotomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Length of hospital stayup to 24 weeks

Count the total days of hospitalization

Secondary Outcome Measures
NameTimeMethod
Sequential organ failure assessment (SOFA) scoremeasured at 48 hours, 7 days and 14 days

The SOFA score is a simple and objective score that allows for calculation of both the number and the severity of organ dysfunction in six organ systems (respiratory, coagulatory, liver, cardiovascular, renal, and neurologic), and the score can measure individual or aggregate organ dysfunction.The SOFA score ranges from 0 to 24; higher scores mean a worse outcome.

CRPmeasured at 48 hours, 7 days and 14 days

Inflammatory mediator, CRP

IL-6measured at 48 hours, 7 days and 14 days

Inflammatory mediator, IL-6

TNF-αmeasured at 48 hours, 7 days and 14 days

Inflammatory mediator, TNF-α

IL-1βmeasured at 48 hours, 7 days and 14 days

Inflammatory mediator, IL-1β

WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item versionmeasured at 3 and 6 months

WHODAS 2.0 is used to measure of disability after major trauma.

Peripheral Blood Mononuclear Cell (PBMC) analysismeasured at 48 hours, 7 days and 14 days

PBMC analysis by flow cytometry

IL-10measured at 48 hours, 7 days and 14 days

Inflammatory mediator, IL-10

Trial Locations

Locations (1)

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Kaohsiung Chang Gung Memorial Hospital
🇨🇳Kaohsiung, Taiwan
Chun-Ting Liu, MD
Contact
+886-7-7317123
juntin0214@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.